Monopar Therapeutics Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2021 | $1.6M | $20.5M | $20.3M |
| FY2022 | $3.1M | $13.2M | $8.2M |
| FY2023 | $1.8M | $7.3M | $7.3M |
| FY2024 | $5.3M | $60.3M | $45.8M |
| FY2025 | $2.9M | $140.7M | $61.8M |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2021 | $1.6M | $20.5M | $20.3M |
| FY2022 | $3.1M | $13.2M | $8.2M |
| FY2023 | $1.8M | $7.3M | $7.3M |
| FY2024 | $5.3M | $60.3M | $45.8M |
| FY2025 | $2.9M | $140.7M | $61.8M |